{"id":"W2010378709","doi":"10.1038/ng879","title":"Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations","year":2002,"lang":"en","type":"article","venue":"Nature Genetics","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1109,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; Women's College Hospital; University of Toronto","funders":"Abramson Family Cancer Research Institute; Cancer Research UK; National Cancer Institute; KWF Kankerbestrijding; Deutsche Krebshilfe; Cancer Research Institute","keywords":"CHEK2; Breast cancer; Biology; Penetrance; Checkpoint Kinase 2; Cancer research; Cancer; Ovarian cancer; Mutation; Genetics; Oncology; Internal medicine; Germline mutation; Gene; Cell cycle; Cell cycle checkpoint; Phenotype; Medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00990067067864628,"score_gpt":0.2883313008485704,"score_spread":0.2784306301699241,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}